were also able to demonstrate EB virus IgM in cases of infectious mononucleosis by immunofluorescence.
In 1971 Hampar et al demonstrated by immunoferritin electron microscopy the presence of EB virus IgM in fractions of sera from cases of infectious mononucleosis but not from healthy persons with EB viral capsid antigen (VCA) IgG titres. Banatvala et al (1972) and Schmitz and Scherer (1972) were also able to demonstrate EB virus IgM in cases of infectious mononucleosis by immunofluorescence.
As IgM is the antibody present during acute infection this evidence confirmed the connection between infectious mononucleosis and primary infection with EB virus. This had already been clearly indicated by the work of Niederman et al (1970) in the USA. They studied university student cases of infectious mononucleosis from whom stored pre-illness sera were available. They had found, using the immunofluorescence test for EB viral capsid antigen (VCA) IgG described by Received for publication 13 January 1976 Henle and Henle (1966) , that cases with heterophil antibody positive infectious mononucleosis converted from IgG negative to IgG positive and that no student already positive for EB IgG developed true infectious mononucleosis at a later date. As (University Health Physicians, 1971) . Using sera from this source and from diagnostic specimens received in the Central Middlesex Hospital laboratory for routine heterophil antibody tests the pattern of specific EBV IgG and IgM and heterophil antibody has been studied in order to: 1 demonstrate the range of EBV IgG titres in acute and convalescent sera from student cases of infectious mononucleosis related to EB virus infection and from cases with similar symptoms but not related to EB infection and to compare these with titres in sera from students who, from previous tests, were known to possess EB antibody and to have been symptomless during the previous six months; 2 show the pattern of disappearance of EBV IgM and heterophil antibody after an attack of infectious mononucleosis; and 3 distinguish between specific EBV IgM staining and false positive staining due to the presence of EBV IgG with rheumatoid factor (anti-IgG macroglobulin) in the same serum.
Serum specimens studied GROUP A FROM UNIVERSITY STUDENTS 1 Paired acute and convalescent sera from 193 students with suspected infectious mononucleosis. 2 Pre-illness sera from 166 of these 193. Pre-illness sera were not available from the remaining 27 students but in all of these the acute illness specimens were negative for EB antibodies. 3 The diagnosis of IM was confirmed in 97 of the 193 suspected cases and post-convalescent sera were obtained from 61 of these positive cases. 4 Sera from 91 students taken six months after entry. These students were chosen because their entry sera had been positive for EB IgG. The second sera were titrated to give a normal distribution curve for EB IgG in students who had been healthy and had had EB IgG antibody for at least six months.
GROUP B
Four hundred and six single sera received at the Public Health Laboratory of the Central Middlesex Hospital, London from hospital patients and patients of local medical practitioners for diagnostic heterophil antibody test.
Methods
Sera were tested for heterophil antibody by horse erythrocyte agglutination (Davidsohn and Henry, 1969) at the Central Middlesex Laboratory, and for EB specific IgG and IgM by the indirect immunofluorescence test at the Virus Reference Laboratory.
The method of Henle (Sumaya et al, 1975) (Sutton et al, 1974a but positive in the EB IgM test (6 weakly). Of 100 acute and convalescent sera from 59 patients with IM tested for rheumatoid factor, all specimens from 42 students were negative, six students gave a positive result in both specimens, and the pre-illness serum was also positive from four of these students. Eleven gave a weak positive result in the acute specimen only.
All the IM sera tested after density gradient fractionation from group A gave positive EB IgM staining in the macroglobulin fraction whether the presence specimens from the IM cases ranged from less than I in 8 to 1 in 16. Both the students and health physicians were on the alert for the disease so first specimens were taken very soon after onset. In all but one of these cases the convalescent specimen revealed a four-fold rise in titre. Of the 96 cases who did not have IM, 37 % had no EB IgG at a dilution of 1 in 8 either at onset or in convalescence. By titrating paired specimens, therefore, the diagnosis could have been confirmed or excluded in 40% of the 193 suspect cases. On the other hand, the same conclusion could have been reached from the heterophil antibody test results. When the cases which were EB IgG negative in both acute and convalescent specimens are removed from the graph of heterophil antibody negative cases it will be found that the percentage curves calculated for the remaining 60 EB IgG positive cases approximate to those of the convalescent IM cases and the healthy students. In the latter there is a preponderance of titres of 1 in 128. This may be a genuine phenomenon but deviation to 1 in 64 or 256 is within the experimental error of the test. These curves indicate that an EB IgG titre in the range 1 in 32 to 1 in 512 in our test in a single specimen of serum is uninformative as this range of titres is common to healthy students, non-IM cases and convalescent IM cases alike. It is important to remember that the scale of titre varies from laboratory to laboratory largely because of differing techniques and optical equipment (Geser et al, 1974) . Each laboratory therefore has to set its own normal distribution curve. However, if the titre of the Standard serum described and the method of reading were quoted with the work of each laboratory useful comparisons could be made.
Close agreement is shown between the HA and EB IgM tests (table II) on the 406 sera of group R.
The time in relation to onset of these sera is not known; possibly the sera which are not concordant could be very early or late specimens, times when of the two only one may be positive. The tests for rheumatoid factor, which revealed four false positive EB IgM results confirmed by tests after density gradient fractionation, explain some if not all the EB IgM positive results in the absence of HA. The ages of two of these patients were known and they were over 40 years of age. It has been said repeatedly that in cases of infectious mononucleosis under the age of 10 the HA tests are often not positive. However, in our group B sera we did not find any from this age group positive for EB IgM and negative for HA so we have no evidence to support this statement. Unfortunately the ages of only 212 of the 406 patients in group B were known, and the accurate date of onset of illness was rarely available. Of those 212 whose age was known, only 27 (13 %) were under 10 years of age. This means either that IM-like illness is uncommon or that doctors are disinclined to take blood specimens at that age.
The sera of nine of these 27 were negative in all tests. These children had either never had an EB infection or were very early cases. The sera from six were positive in all three tests, showing that at least some EB infections under 10 years have an illness resembling infectious mononucleosis and with an HA response. Twelve sera were positive only for EB IgG and were therefore from children with a past infection with EB virus or who were late cases from whose sera the other antibodies had already disappeared. They are unlikely to have been very early cases as, from the student figures (line 3  of table I 
